Projects funded by the NCN
Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cognitive disorders in Alzheimer's disease.
2018/31/D/NZ7/01433
Keywords:
depression dementia Alzheimer's disease multitarget ligands
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
- ST5_23:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: SONATA 14 - announced on 2018-09-14
Amount awarded: 870 500 PLN
Project start date (Y-m-d): 2019-07-11
Project end date (Y-m-d): 2024-07-10
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.